Re: Indirect Cost (F&A) Rates Charged on Clinical Trials Surprenant, James M. 23 Feb 2008 06:57 EST
Hi Tina, The Clinical Trial IDC rate at the Brigham and Women's Hospital in Boston is 25%. Please let me know if you need additional information - I'd like to receive a copy of the revised final survey as well. Take care, James JAMES M. SURPRENANT, MBA Department of Surgery BRIGHAM AND WOMEN'S HOSPITAL Tel: 617-525-7409 ¨ Fax: 617-525-7723 -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Tina Noonan Sent: Friday, February 22, 2008 2:29 PM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] Indirect Cost (F&A) Rates Charged on Clinical Trials Here at Indiana University, we are currently charging 25% on industry- sponsored clinical trials. And, yes, this is a different rate than our federally negotiated rate. I've attached a rate survey that I worked on last year for a different listserv, and it was updated in November based on conversations one of my colleagues had with other institutions at NCURA. If anyone would like to add to this survey, or provide more up-to-date information about your institution, please contact me at xxxxxx@iupui.edu. I will then compile the responses and post an update to this listserv. Also, for those who have increased their rates during the last couple of years (particularly if you went to 30% or above), could you let me know what reaction you got from sponsors? Did you see a decrease in studies? (And, thank you Pam for providing this information about U of Mississippi.) Tina Noonan Interim Director, Award Services Indiana University Indianapolis, IN ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== The information transmitted in this electronic communication is intended only for the person or entity to whom it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of or taking of any action in reliance upon this information by persons or entities other than the intended recipient is prohibited. If you received this information in error, please contact the Compliance HelpLine at 800-856-1983 and properly dispose of this information. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================